Intravitreal bevacizumab for adult-onset vitelliform dystrophy: A case report

European Journal of Ophthalmology

Volumn 17, Issue 6, 2007, Pages 983-986

  Montero, Javier A ^a,b   Ruiz Moreno, J M ^b,c   De La Vega, C ^b  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b Alicante   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Adult onset foveomacular vitelliform dystrophy; Age related macular degeneration; Bevacizumab; Choroidal neovascularization; Retinal pigment epithelium dystrophy

Indexed keywords

BEVACIZUMAB;

ADULT ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTERVENTION STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINITIS PIGMENTOSA; SINGLE DRUG DOSE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 39349105310     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700620     Document Type: Article

References (5)

1. Ergun E, Costa D, Slakter J, Yannuzzi LA, Stur M. Photodynamic therapy and vitelliform lesions. Retina 2004; 24: 399-406.
2. Glacet-Bernard A, Soubrane G, Coscas G. Dégéné rescence maculaire vitelliforme de l'adulte. Etude rétrospective d'une série de 85 patients. J Fr Ophtalmol 1990; 13: 407-20.
3. Benhamou N, Souied EH, Zolf R, Coscas F, Coscas G, Soubrane G. Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography. Am J Ophthalmol 2003; 135: 362-7.
4. Cardillo Piccolino F, Zingirian M. Pattern dystrophy of the retinal pigment epithelium with vitelliform macular lesion: evolution in ten years. Int Ophthalmol 1988; 11: 207-17.
5. Lazic R, Gabric N. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 68-73.